The management of terminal carcinoma with oral potassium permanganate.
Oral potassium permanganate has been used in the management of terminal carcinoma in three patients. Symptomatic improvement occurred in all three, with elimination of oral foetor in one patient and diminished requirement of analgesics in the other two. The mental state of each patient was improved and normal activities were resumed.
D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009062:Mouth Neoplasms / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D010166:Palliative Care; D010190:Pancreatic Neoplasms / Q000188:drug therapy; D011196:Potassium Permanganate / Q000627:therapeutic use*; D013727:Terminal Care
D011196:Potassium Permanganate